Rallis
to focus on three growth areas
Business
Standard
September 20, 2002
Rallis
India, the agrichemicals arm of the Tatas which
is in the midst of a restructuring, has identified
farm management services, specialty fertilisers
and seeds as its future growth areas. The company
is also stepping up its exports in pesticides.
"The
company will shift its focus from the US, western
Europe destinations to south-east Asia, Australia,
Africa, Sri Lanka and Vietnam," Rajeev Dubey,
managing director, said. Freddie Mehta, chairman,
said, "For the company, the ongoing year
is going to be a tough one for a variety of reasons."
The poor monsoon, the economy in general will
have a impact on the company. The total impact
of the delay in monsoons on the pesticides industry
will be 10-15 per cent in 2002-03.
The
company had undertaken initiatives which included
sharpening of business and product portfolios,
introduction of new products and reducing costs.
The company(including its subsidiaries) has also
reduced its workforce by 935 employees from 3,120
employees in September 2000. Mehta said, "The
merger of five wholly owned subsidiaries(except
Siris India) with itself, could not be completed
with effect from
April 1, 2001 owing to non-receipt of certain
NOCs. The board has therefore decided to reconsider
the date of merger with effective April 1, 2002."
The
five subsidiaries have a combined loss of Rs 36
crore for the year ended March 31, 2002, of which
operating losses are Rs 9 crore and non-operational/one
time losses are Rs 27 crore.
"In
anticipation of the merger in the current financial
year, the company has retained an appropriate
amount in its surplus account, for the year ended
march 31, 2002 to absorb this loss, and the implementation
of the scheme of amalgamation will not have any
adverse impact on the profits for the current
financial year, Mehta said. During the year, Rallis
received extraordinary one-time cash inflows of
Rs 174 crore from four sources—from the sale of
Andheri land (Rs 116 crore), the balance sale
proceeds from the sale of pharmaceutical business
(Rs 17.4 crore), post assessment tax refund (Rs
34 crore) and sale of Chennai property (Rs 6 crore).
"Between
Rallis and Ralchem, we reduced the overall indebtedness
by as much as Rs 164 crore. Rs 123 crore of reduction
of debt in Rallis and Rs 41 crore in Ralchem.
We made a settlement with the State Bank of India
and ICICI Bank to resolve long standing matters
which cost us Rs 19 crore," Mehta said. The
company had also refinanced Rs 122 crore of high-cost
borrowings with low-cost fresh debts.
Rallis
and Ralchem’s total borrowings has reduced significantly
from Rs 668 crore in December 31, 2000 to
Rs 445 crore as on March 31, 2002. Its cash from
operations increased by Rs 35 crore for 2001-02.
|
|